Form 4: Seres Therapeutics Executive Sells Shares to Cover Taxes
SEC Form 4
Thomas DesRosier, Chief Legal Officer and EVP of Seres Therapeutics, sold 843 shares of common stock on May 15, 2024, to cover taxes related to vesting restricted stock units.
Summary
- On May 15, 2024, Thomas DesRosier, the Chief Legal Officer and EVP of Seres Therapeutics, sold 843 shares of common stock at a price of $0.94 per share.
- This transaction was executed to cover taxes associated with the vesting of restricted stock units, according to a pre-arranged Rule 10b5-1 trading plan adopted on March 2, 2023.
- Following the transaction, DesRosier directly owns 122,390 shares of Seres Therapeutics common stock.
- Additionally, DesRosier holds 29,219 restricted stock units, each representing a contingent right to receive one share of Issuer common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing simply reports an executive's stock sale for tax purposes under a pre-existing plan. It doesn't inherently indicate positive or negative views on the company's prospects.
Future Outlook
The remaining restricted stock units will vest and settle in 12 equal quarterly installments.
Industry Context
This is a routine Form 4 filing, indicating insider transactions. It's common for executives to sell shares to cover tax obligations related to vesting equity compensation. The existence of a 10b5-1 plan suggests the executive is following a pre-determined strategy.
Stakeholder Impact
- The sale of shares by an executive could have a minor negative impact on shareholder sentiment, but the impact is likely to be minimal given the reason for the sale (tax obligations) and the existence of a pre-arranged trading plan.
Key Dates
| Date | Description |
|---|---|
| March 2, 2023 | Date of adoption of Rule 10b5-1 trading plan |
| February 15, 2024 | 25% of restricted stock units vested and settled |
| May 15, 2024 | Date of stock sale and vesting of restricted stock units |
| May 17, 2024 | Date of signature on the Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.